EXHIBIT 1

 

JOINT FILING AGREEMENT

 

In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13D referred to below) on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the Common Shares, no par value, of Aurinia Pharmaceuticals Inc., and that this Agreement be included as an Exhibit to such joint filing. The Agreement may be executed in any number of counterparts all of which taken together shall constitute one and the same instrument.

 

IN WITNESS WHEREOF, the undersigned hereby execute this Agreement this 4th day of March, 2025.

 

TANG CAPITAL MANAGEMENT, LLC

 

By: /s/ Kevin Tang  
  Kevin Tang, Manager  

 

/s/ Kevin Tang  
Kevin Tang  

 

TANG CAPITAL PARTNERS, LP

 

By: Tang Capital Management, LLC, its General Partner

 

By: /s/ Kevin Tang  
  Kevin Tang, Manager  

 

TANG CAPITAL PARTNERS INTERNATIONAL, LP

 

By: Tang Capital Management, LLC, its General Partner

 

By: /s/ Kevin Tang  
  Kevin Tang, Manager  

 

TANG CAPITAL PARTNERS III, INC

 

By: /s/ Kevin Tang  
  Kevin Tang, Chief Executive Officer  

 

TANG CAPITAL PARTNERS IV, INC

 

By: /s/ Kevin Tang  
  Kevin Tang, Chief Executive Officer